Prevention of Late-life Cognitive Disorders: Diet-Related Factors, Dietary Patterns, and Frailty Models

Abstract

The need for preventing or postponing the onset of Alzheimer’s disease (AD) and delaying or slowing its progression is a direct consequence of the current symptomatic approach of existing drugs for the treatment of AD. Dietary factors may affect the risk of AD and dementia, with a substantial body of evidence suggesting that certain diets have been associated with a lower incidence of AD and late-life cognitive disorders. Among healthy diets, higher adherence to a Mediterranean-type diet and to the Dietary Approaches to Stop Hypertension diet was associated with decreased cognitive decline, although the Mediterranean diet (MeDi) combines several foods, micro-, and macronutrients already separately proposed as potential protective factors against dementia. Higher adherence to the MeDi was associated with a reduced risk of cognitive impairment, MCI, and AD, as well as the transition from MCI to AD, and decreased all-causes mortality in AD patients. Influencing some age-related conditions, such as frailty, may have an impact on the prevention of late-life cognitive decline. Frailty reflects a nonspecific state of vulnerability and a multisystem physiological change and it is a widely recognized risk factor for adverse health outcomes in older persons. At present, no operational definition has been established, although nutritional status, cognition, and mood have been proposed as markers of frailty. Physical frailty may be associated with late-life cognitive impairment/decline, incidence of AD, vascular dementia, non-AD dementias, and AD pathology in older persons with and without dementia, also suggesting the definition of cognitive frailty as a new clinical condition. The reviewed evidence supports the hypothesis that frailty could be important in the prevention of late-life cognitive disorders, and nutritional influences may be of major relevance. Nutritional interventions might be able to address the impaired nutrition and weight loss of frailty. There is a critical need for randomized, controlled trials investigating the role of nutrition on late-life cognitive disorders and frailty that might open new routes for the prevention and management of cognitive decline and AD, supplementing existing symptomatic approaches, also through the nutritional prevention of frailty.

Introduction

The greatest known risk factor for Alzheimer’s disease (AD) is advancing age and, due to aging populations, dementia and late-life cognitive disorders are reaching epidemic proportions [1]. The causes of AD and dementia syndromes are, at present, unclear, but some studies have suggested that they may be prevented [27]. In a general rethinking of the field, the 2011 criteria developed by National Institute on Aging and the Alzheimer’s Association proposed three stages of AD, i.e., preclinical AD, mild cognitive impairment (MCI) due to AD, and dementia due to AD [810], different from the stages currently used to describe AD, also suggesting that the disease begins before the development of symptoms and that new diagnostic procedures may have the potential to identify brain changes that precede the development of symptoms [10]. In fact, recent studies on familial [11] and sporadic AD [12•] showed a prolonged preclinical phase of more than two decades before the onset of dementia in which β-amyloid (Aβ) deposition is slow and protracted, so confirming the new proposed diagnostic procedures [810], and suggesting prevention trials in asymptomatic genetic forms of AD and in cognitively normal individuals suspected to be at an asymptomatic stage of sporadic AD. However, these amyloid-based prevention trials started only at the end of 2013 [13], and lowering the burden of Aβ with a strategy against the production and the accumulation of this peptide have represented a large portion of the many therapeutic approaches currently under development for the treatment of AD [14, 15]. However, drugs currently used for the treatment of AD produce limited clinical benefits, partially stabilizing patients’ symptoms, without disease-modifying potential. Therefore, at present, the management of potential risk factors is believed to be the most effective means of preventing dementia, AD, and MCI.

Growing epidemiological evidence supported the hypothesis that modifiable vascular, metabolic, and lifestyle-related factors were associated with the development of cognitive disorders in late life, opening new routes for the prevention and management of these syndromes [2, 57]. Currently, one of the most intriguing and appealing links hypothesized in recent years is the association between lifestyle factors, such as diet and dietary habits, and the occurrence of AD [1618]. If advancing age is the driving risk factor for AD, some age-related conditions may be strictly linked to dementia and late-life cognitive disorders. Among these conditions, frailty is a multidimensional geriatric syndrome reflecting a nonspecific state of vulnerability and a multisystem physiological change [19]. Frailty also has been associated with an increased risk of adverse health-related outcomes in older persons, including falls, disability, hospitalizations, and mortality [19, 20]. Genetic, epigenetic, and environmental factors, such as nutrition and physical activity, are strongly related to frailty [21•, 22•]. However, not only physical but also psychological, cognitive, and social factors contribute to this multidimensional syndrome and need to be taken into account in its definition and treatment. Cognition already has been considered as a component of frailty [23], and it has been demonstrated that it is associated with adverse health outcomes [24, 25]. Therefore, the prevention of frailty is important in preventing cognitive-related adverse health outcomes, including delirium [26] and late-life cognitive disorders [27]. In this narrative review article, we examined the possible role of macronutrients, food nutrients, dietary patterns, and different frailty models in modulating the risk of AD, dementia, and late-life cognitive disorders, with a focus on the role of nutrition on frailty, in an attempt to explain some underlying mechanisms of the proposed associations between diet-related factors and cognition in older age.

Diet-Related Factors, Dietary Patterns, and Late-Life Cognitive Disorders

Micro-, Macronutrients, Foods, and Food Groups and Cognition

Deficiencies of some micronutrients (especially, vitamins B1, B2, B6, B12, C, and folate) have been described quite frequently in older people and found to be significantly associated with cognitive impairment [17]. In fact, for example, there is a large body of evidence that maintaining healthy vitamin C levels can have a protective function against AD, but avoiding vitamin C deficiency is likely to be more beneficial than taking supplements [28]. In observational studies and in preclinical models of AD, dietary supplementation of antioxidants [29], B vitamins [30], and polyphenols [31] appeared to be beneficial for AD [32, 33], although many of the results from randomized, controlled trials are contradictory to that of epidemiological and animal studies [34, 35]. Furthermore, a recent population-based study, the Québec Longitudinal Study on Nutrition and Successful Aging, found that low levels of phylloquinone (vitamin K) were related to poor verbal episodic memory performance in older individuals free of cognitive impairment [36].

However, while the impact of micronutrients in cognitive decline has been extensively investigated, few data were available on the role of macronutrient intakes and single foods or food groups in the pathogenesis of age-related cognitive decline and dementia syndromes [5, 17, 18, 33, 37, 38]. Elevated saturated fatty acids could have negative effects on age-related cognitive decline and MCI [39]. Furthermore, at present, epidemiological evidence suggested a possible association among fish consumption, monounsaturated fatty acids (MUFA) [40, 41], and polyunsaturated fatty acids (PUFA) (particularly, n-3 PUFA) and reduced risk of cognitive decline, AD, and dementia [39, 42, 43]. Data from randomized, controlled trials (RCTs) showed that supplementation with docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) compared with placebo did not slow the rate of cognitive decline and functional decline [4446]. However, in the PREDIMED-NAVARRA, a RCT with a follow-up of 6.5 years in older persons, the group supplemented with an extra-virgin olive oil supplement, very rich in MUFA content, had better cognitive performance, and was less likely to become demented [47••]. The contradictory results between observational studies and RCTs might be due to the duration of RCTs, often not long enough. Therefore, based on the current evidences from human and animal studies, it is not possible to make definitive dietary recommendations in relation to the AD risk on fish consumption and the lower intake of saturated fat from meat and dairy products [39, 48] as well as on unsaturated consumption or lower intake of saturated fat in relation to the risk for dementia and cognitive decline. However, a high consumption of fats from fish, vegetable oils, vegetables, and nuts should be encouraged because this dietary advice is in accordance with recommendations for lowering the risk of cardiovascular disease, obesity, diabetes, and hypertension [39, 48].

Among macronutrient intakes, single foods, and food groups, poorer cognitive function [49•], and an increased risk for vascular dementia (VaD) [50] were found to be associated with a lower consumption of milk or dairy products. However, the consumption of whole-fat dairy products may be associated with cognitive decline in the elderly [5]. The limited available literature supported the concept that high dairy consumption may be associated with a lower likelihood of cognitive impairment; however, high intakes of full-fat dairy and/or dairy fats may be associated with declines in cognitive performance [49•, 51]. Dairy may reduce the risk for cognitive impairment by modifying vascular factors linked to detrimental brain changes, particularly via weight reduction [5]. Multiple mechanisms associated with diabetes-related glucose and insulin dysregulation can lead to vascular and neuronal damage [6]. During the past two decades, multiple studies have examined the possible association of diabetes mellitus and different forms of dementia and cognitive impairment [52]. Therefore, a diet high in carbohydrates may be detrimental to AD [53, 54]. However, glycemic load reflexing carbohydrate content in food was not associated with a higher risk of AD [55], not supporting low carbohydrate diets for the prevention of AD in older age. No reliable data from RCTs on a diet high in carbohydrate and AD were available [32]. The limited epidemiological evidence available on fruit and vegetable consumption and cognition generally supported a protective role of these macronutrients against cognitive decline, dementia, and AD [5]. However, a very recent meta-analysis on six studies analyzed fruit and vegetables separately and five of them found that higher consumption of vegetables, but not fruit, was associated with a decreased risk of dementia or cognitive decline in older age [56].

Among diet-associated factors, some case-control and cross-sectional and longitudinal population-based studies evaluated the long-term effects on brain function and provided some evidence that coffee, tea, and caffeine consumption or higher plasma caffeine levels may be protective against cognitive impairment and dementia [57, 58, 59•]. In particular, several cross-sectional and longitudinal population-based studies suggested a protective effect of coffee, tea, and caffeine use against cognitive impairment/decline, although the association was not found in all cognitive domains investigated and there was a lack of a distinct dose-response association, with a stronger effect among women than men [59•]. Furthermore, for dementia and AD prevention, some studies with baseline examination in midlife pointed to a lack of association, although other case-control and longitudinal population-based studies with briefer follow-up periods supported favourable effects of coffee, tea, and caffeine consumption against AD [57, 58]. Finally, light-to-moderate alcohol use may be associated with a reduced risk of incident dementia and AD, whereas for VaD, cognitive decline, and predementia syndromes the current evidence is only suggestive of a protective effect [60]. Indeed, the body of epidemiological evidence of all research published within the past 10 years suggested that light-to-moderate alcohol use may be associated with a reduced risk of unspecified incident dementia and AD, whereas for VaD, cognitive decline, and predementia syndromes, the current evidence is only suggestive of a protective effect [6163]. Protective effects of moderate alcohol consumption against cognitive decline are suggested to be more likely in the absence of the AD-associated apolipoprotein E (APOE) ε4 allele and where wine is the beverage [60]. At present, there is no indication that light-to-moderate alcohol drinking would be harmful to cognition and dementia, and attempts to define what might be deemed beneficial levels of alcohol intake in terms of cognitive performance would be highly problematic and contentious [60].

Dietary Patterns and Late-Life Cognitive Decline

Dietary factors may affect the risk of cardiovascular disease, also influencing the risk of AD and dementia [40, 64], with a substantial body of evidence suggesting that certain diets have been associated with a lower incidence of AD and late-life cognitive disorders [6567, 68•, 69, 70, 71•, 72•, 73]. Single-nutrient analyses ignored the complexity of the diet, and defining dietary exposures as a dietary pattern, a combination of food components that summarizes an overall diet for a study population, may better predict disease risk [74].

Compared with traditional single-food or nutrient methods, the whole-diet or dietary pattern approach is appealing for several reasons. Indeed, the analyses of single nutrients ignore important interactions (additive, synergistic, or antagonist effects) between components of diet and more importantly people did not eat isolated nutrients [5]. Among different dietary patterns, in a recent Japanese population-based study, higher adherence to a dietary pattern characterized by a high intake of soybeans and soybean products, vegetables, algae, and milk and dairy products and a low intake of rice was associated with reduced risk of dementia [71•]. These findings suggested that a traditional Japanese diet characterized by increased intake of fish and plant foods (soybean products, seaweeds, vegetables, and fruits) and decreased intake of refined carbohydrates and animal fats (meat) may be protective against dementia. On the contrary, a high-fat Western diet characterized by higher intake of red and processed meats, refined grains, sweets, and desserts may contribute to the development of AD with increased Aβ deposition and oxidative stress [75, 76]. Although epidemiological findings from studies exploring Western diet and the risk of AD were not available [32], a dietary pattern similar to that of Western diet and characterized by a high intake of meat, butter, high-fat dairy products, eggs, and refined sugar has been found in AD patients in a small study [77]. Another study also have examined a posteriori-extracted dietary patterns in relation to AD, with a dietary pattern strongly associated with lower AD risk and characterized by higher intakes of salad dressing, nuts, fish, tomatoes, poultry, cruciferous vegetables, fruits, and dark and green leafy vegetables and a lower intake of high-fat dairy products, red meat, organ meat, and butter [78]. Two other studies have focused on the cross-sectional link between cognitive function and “healthy” dietary patterns extracted by cluster analysis [65, 79]. In fact, a healthy diet, characterized by higher consumption of fish by men and fruits and vegetables by women, was also reported to be associated with better cognitive performance [65]. In another population-based study, higher intake of “whole food” diet (rich in fruit, vegetables, dried legume, and fish) was associated with lower and high consumption of “processed food” (rich in processed meat, chocolates, sweet desserts, fried food, refined cereals, and high-fat dairy products) with higher odds of cognitive deficit [79]. Furthermore, two population-based studies used middle-age dietary exposure assessment, which is critical when focusing on diseases requiring several decades to develop [67, 69]. In a first study on 525 subjects, persons with a high adherence to healthy diet in mid-life, with healthy diet index >8 points (an index constructed to assess healthy and unhealthy diet components), had a decreased risk of AD after a 14-year follow-up [67]. Finally, in the Supplementation en Vitamines et Minéraux Antioxydant, 1994–2002 (SU.VI.MAX) study, in a cohort of 3,054 participants, adherence to a healthy dietary pattern in mid-life (consumption of fruit, whole grains, fresh dairy products, vegetables, breakfast cereal, tea, vegetable fat, nuts, and fish) was positively associated with better cognitive functioning, independently of other health behavior factors [69].

Therefore, maintaining a healthy diet may have an impact on many possible risk factors for cognitive decline, and the models to follow seem to be the Mediterranean diet (MeDi) and the Dietary Approaches to Stop Hypertension (DASH) diet [68•, 70, 72•, 73]. In particular, the DASH diet, a recommended dietary plan for all Americans, especially those with hypertension [80, 81], contains a high intake of plant foods, fruits, vegetables, fish, poultry, whole grains, low-fat dairy products, and nuts, while minimizing intake of red meat, sodium, sweets, and sugar-sweetened beverages. In a RCT on 124 participants with elevated blood pressure, subjects on the DASH diet or with DASH dietary modification plus weight loss exhibited greater cognitive improvements compared with control subjects [82••]. In the population-based Cache County Memory Study (CCMS), the DASH score was one of six behaviors assessed in relation to incident dementia or AD, with dietary behaviors in conjunction with others associated to a decreased risk of incident dementia in a 6-year follow-up [83]. In another analysis from the CCMS, a significant reduction in rates of global cognitive decline was observed with higher levels of accordance with both the DASH and Mediterranean-style dietary patterns in older men and women during an 11-year period [84••]. The Mediterranean-style diet is characterized by abundant plant foods consumption in the form of fruits, vegetables, breads, other forms of cereals, potatoes, beans, nuts and seeds; fresh fruit as the typical dessert; olive oil as the main source of MUFA; dairy products as principally cheese and yogurt; a low-to-moderate consumption of fish; a low-to moderate consumption of poultry; fewer than four eggs consumed per week; low amount of red meat and wine consumed in low-to-moderate amounts, normally during meals [50]. Adherence to a Mediterranean-type diet could be associated with slower cognitive decline, reduced risk of progression from MCI to AD, reduced risk of AD, and decreased mortality in AD patients, with some notable exceptions [5, 72•, 85]. Some very recent systematic reviews and meta-analyses found that a higher adherence to the MeDi was associated with a reduced risk of cognitive impairment, MCI, and AD, as well as the transition from MCI to AD [68•, 86, 87]. Two RCTs are available on this topic [88, 89••]; one found inconsistent results although with an inordinately short follow-up of only 10 days [88], whereas the PREDIMED-NAVARRA suggested that nutritional intervention with MeDi supplemented with either extra-virgin olive oil or mixed nuts was associated with improved global cognition in a 6.5-year follow-up, independently of potential confounders [89••]. This evidence is confirmed by a specific nutrient/food model based of the MeDi in which elevated dietary MUFA, n-3 PUFA, and high fish consumption, alongside high levels of antioxidants from fruit and vegetables, and moderate alcohol consumption may have a beneficial effect on the risk of dementia [73].

Cognitive Frailty: Epidemiological Evidence of a New Clinical Condition

Operational Definitions of Frailty and Proposed Models

Among potentially modifiable risk factors, the impact of several operational definitions of frailty [19, 24, 25] (Table 1) on late-life cognitive decline and dementia has been the subject of recent interest [27, 90•]. Epidemiological and clinical studies focused their attention on an increasingly important concept in both clinical care of older persons and research in aging, i.e., frailty, a biological syndrome of decreased ability to respond to stressors and an increased vulnerability to adverse outcomes [19]. However, frailty is, at present, a more elusive concept, and how best to operationalize this syndrome is still controversial [91]. Some definitions are based on physical diminution in the elderly person [19, 92, 93]. In particular, the “phenotypic” or physical definition of frailty or the “biological syndrome model” was proposed by Fried and colleagues working with the Cardiovascular Health Survey (CHS) [19]. By convention, the CHS definition of physical frailty proposes five items: unintentional weight loss, exhaustion, weakness, slow walking speed, and low levels of physical activity. An older individual is said to be frail when three or more are present, “pre-frail” when they exhibit only one or two of these characteristics, and “robust” when they have none [19]. Other definitions, criticizing this concept [9497], suggested that an integral approach is needed for the concept of frailty, an approach in which the focus is not exclusively on physical problems in older people, but which also incorporates psychological and social problems, and is thus based on the integral functioning of the individual [98, 99]. A recent integral conceptual working definition of frailty takes into account of the principles formulated earlier and combines essential components of existing conceptual definitions of frailty [98, 99]. This definition indicates frailty as a dynamic state affecting an individual who experiences losses in one or more domains of human functioning (physical, psychological, social), which is caused by the influence of a range of variables and which increases the risk of adverse outcomes [99]. Therefore, an emerging consensus promotes a definition of frailty on the basis of a multidimensional approach [99102], so the evaluation of frailty employs a frailty index, which is calculated by considering a number of potential deficits. These deficits can be symptoms, signs, diseases, disabilities or abnormal laboratory values [102], so developing an integral conceptual definition of frailty as a multisystem physiological change occurring in the elderly that determine an increase of risk for accelerated physical and cognitive decline, disability and death even in absence of specific diseases [99102]. Therefore, the second model that emerged in recent years is the frailty index based on accumulation of deficits or cumulative burden index proposed by Rockwood and collegues [103, 104], in which frailty is defined as an accumulation of health conditions and deficits.

Table 1 Principal studies on the association of different operational definitions of frailty or frailty instruments with late-life cognitive decline, mild cognitive impairment (MCI), dementia, Alzheimer’s disease (AD), vascular dementia (VaD), and other different cognitive outcomes

Cognitive Frailty: Multidimensional and Phenotypic Approach

In physical or phenotypic frailty [19] or in frailty indexes with a multidimensional nature [103, 104], this clinical syndrome is generally associated with a greater risk for adverse health-related outcomes, such as falls, disability, hospitalization, permanent institutionalization, and death [105•]. However, in recent years, the prevention of frailty may be important in preventing cognitive-related adverse health outcomes, including delirium [26] and late-life cognitive disorders [27, 90•]. Therefore, physical frailty [106, 107], psychological frailty, and social frailty cannot be seen in isolation from each other, and, in particular, cognition has already been considered as a component of frailty [23]; indeed, this conceptualization of frailty is based on a holistic view of the person [99101]. In fact, in recent years, frailty is acknowledged to be not only a biological or physiological state, but also a multidimensional concept [20, 102, 108]. The multidimensional nature of the concept of frailty demands a multidisciplinary approach.

A list of eight frailty risk factors that are mentioned to be of great importance to the concept of frailty were identified in a systematic review that evaluated clinimetric properties [102], including in the physical dimension: nutritional status, physical activity, mobility, strength, and energy, in the psychological dimension: cognition and mood, and in the social dimension: lack of social contacts and social support. On this basis, at least 20 frailty instruments have been described [102], and cognition was present in only 40 % of them [27]. All these frailty instruments are multidimensional in nature, and mostly based on a standardized Comprehensive Geriatric Assessment (CGA) [27, 109, 110]. However, the overall results of the assessment by using these frailty instruments suggested that they are mainly developed and validated as risk assessment tools, and not as possible outcome measures [102]. Only a few studies made a comparison between frailty instruments, concluding that different instruments may identify older people at risk of adverse health outcome [111], but they may capture different subpopulations [112, 113]. In particular, in older individuals institutionalized in nursing homes, comparing the CHS physical definition of frailty [19], the Canadian Study of Health and Aging (CSHA) Clinical Frailty Scale [25], and the Frailty Index [111], whereas all these frailty measures were significantly associated with an increased risk of mortality, disability and cognitive decline, measured with the Mini Mental State Examination (MMSE) in its modified form (3MS), when pairs of frailty measures were included in the models, only the Frailty Index was associated with a higher risk of mortality and decline in the 3MS [114] (Table 1). Furthermore, a study examined the relationships among seven frailty domains (nutrition, physical activity, mobility, strength, energy, cognition, and mood), using data from three population-based studies. In two of these studies, presence of deficits for all domains separated from absence of deficits. In the third population-based study, there was separation in all domains except cognition. All these data may suggest that frailty is a multidimensional concept for which the relationships among domains differ according to the population characteristics. These domains, with the possible exception of cognition, appeared to aggregate together and share a common underlying construct [100]. Alternatively, it may be that frailty involves specific aspects of cognition not measured in the three studies, such as executive function or psychomotor speed [106, 107], rather than overall impairment. More recently, the same authors analyzed data from five population-based studies of aging, and among frailty markers consistently aggregated in the five samples, strength had the highest contribution overall in explaining differences among participants across the samples; mobility and energy followed as the next most discriminating markers; and nutrition and cognition appeared to be least discriminating [101]. A Canadian study of 23,952 home care recipients found that 40 % of participants classified in the frailest category using a frailty index based on an accumulation of deficits approach had a diagnosis of dementia compared to 11 % of those in the least frail category [115] (Table 1). Other three Canadian studies, using the population-based sample of the CSHA of adults in the community and institutionalized care, proposed that different measures of frailty at baseline were associated in a 5-year follow-up with cognitive decline [116, 117] and dementia and AD over 5-year and 10-year intervals [118] (Table 1).

Only very few studies explored the multidimensional impairment as a frailty concept in hospitalized older patients. In particular, the Multidimensional Prognostic Index (MPI) was effective in predicting short- and long-term mortality risk in elderly subjects with dementia admitted to a geriatric hospital ward [119] (Table 1), and given that in patients with dementia, clinical outcome and mortality result from a combination of psychological, biological, functional, and environmental factors, tools that effectively identify patients with different life expectancy should be multidimensional in nature. More recently, a multicentre study on 1,306 hospitalized patients in France showed that that screening for frailty with four different indexes based on multidimensional impairment at the beginning of a hospital stay can strongly predict 1-year institutionalization and mortality related to frailty, but not rapid cognitive decline (loss of ≥3 points on MMSE) [120] (Table 1). Overall taken together these findings supported the concept that considering multidimensional aggregate information and frailty syndrome could be very important for predicting short- and long-term all-cause mortality in older subjects with dementia and that it may be important for the identification of the more adequate management of these patients. Finally, a Japanese population-based study also showed a reciprocal relationship, suggesting that cognitive impairment may indicate the development of frailty measured with the CSHA Clinical Frailty Scale [121] (Table 1).

Moreover, the physical or phenotypic definition of frailty has been proposed in several studies linking frailty models and late-life cognitive decline or dementia [27, 90•, 122••]. A series of cross-sectional [23, 123133] and longitudinal studies [19, 23, 134141] investigated the relationship between physical/biological frailty and MCI or late-life cognitive impairment/decline (Table 1). In the cross-sectional component of the Italian Longitudinal Study on Aging (ILSA), both lower cognition and greater depressive symptoms were associated with physical frailty [127]. Other findings from the Three-City Study suggested that cognitive impairment improved the predictive validity of the operational definition of physical frailty, increasing the risk to develop disability. On the contrary, risk of death also tended to be higher in cognitively impaired frail participants than in their non-frail counterparts without cognitive impairment, even if the results were not statistically significant [23]. In the Mexican Study of Nutritional and Psychosocial Markers of Frailty, in which physical frailty phenotype was operalizionated slightly modifying the CHS criteria and cognitive impairment was considered as an additional frailty criterion, low physical activity and cognitive impairment appeared to be the more important contributors of functional disability [124]. In the Jerusalem Longitudinal Cohort Study, prevalence of cognitive impairment (MMSE ≤ 24) in frail older subjects was 53.3 %, with frailty status significantly associated with cognitive impairment [123]. In a population-based study from South Korea, frail older subjects showed a higher percentage of cognitive impairment, with some gender differences (55.8 % in men, 35.2 % in women) [133]. In different population-based studies from Spain and Brazil, the prevalence of cognitive impairment in physical frail older subjects ranged from 20 % [128] to 39 % [129, 130], whereas in a sample of 5,104 older community dwellers in Japan, the combined prevalence of frailty and MCI was only 2.7 %, with a significant relationships between frailty and MCI [132]. Furthermore, in a sample from an Irish tertiary center, frailty was a distinct entity measurable in AD and MCI that correlates with age and increasing comorbid illness rather than markers of cognitive decline and illness severity [125]. Finally, some cognitive domains were found significantly associated with frailty in some cross-sectional studies on community dwelling older people, i.e., executive functions and processing speed [131], and poorer sustained attention [126]. In longitudinal studies, lower cognition was associated with the frailty physical phenotype in the CHS, despite exclusion of those subjects with MMSE < 18 [19]. Several other studies have also reported that physical frailty was associated with low cognitive performance at baseline [134136]. In particular, in the Hispanic Established Populations Epidemiologic Studies of the Elderly (H-EPESE), the baseline MMSE total score was significantly predictive of frailty at 1-year follow-up in men, but not in women [134]. After adjustment, in Three-City Study, frail persons with cognitive impairment were significantly more likely to develop disability over a 4-year period [23]. Two longitudinal population-based studies indicated frailty syndrome as a predictor of cognitive impairment in a 10-year follow-up [138], and of the rate of cognitive decline in a 3-year period [137]. The Rush Memory and Aging Project also found that physical frailty increased the risk for MCI [139], although there is still controversy as to whether cognitive impairment may be a symptom of frailty or whether MCI is a separate syndrome, or indeed, a sign of early dementia [139]. In a large population-based study conducted in Hong Kong, underweight, grip strength and chair stand predicted cognitive decline in men, while only grip strength predicted lower MMSE at follow-up in women [141]. Finally, a study provided preliminary empirical support for the existence of subdimensions of physical frailty within the CHS model [19]. In particular, two subdimensions were identified, and cognitive impairment was part of a frailty subdimension, including slower gait, weaker grip, and lower physical activity, further increasing evidence that physical performance tests are sensitive indicators of cognitive impairment, and further supporting the hypothesis that cognitive impairment may be intrinsic to frailty [140]. In fact, although some have referred to the CHS model of frailty as the “biological” model of frailty (in contrast to other models that include social and psychological criteria), these findings call this into question, because several variables in the CHS phenotype of frailty appear to be integrally related to cognitive impairment [140].

Also when the cognitive outcomes were dementia, AD, or VaD, a series of cross-sectional [142144] and longitudinal studies [137, 145148] investigated these associations with physical/biological frailty (Table 1). In particular, two small Italian studies investigated the prevalence of AD and dementia in patients with frailty identified with Study of Osteoporotic Fractures (SOF) criteria, which operationalized physical frailty with a simpler adaptation of the more complex CHS criteria [142, 143]. In the first study of 109 AD patients attending an outpatient geriatric clinic, 50 % were frail, 28 % were pre-frail, and 22 % were robust [142]. In the second study of 265 outpatients, dementia was identified in 45 % of frail participants compared with 32 % in pre-frail, and 33 % robust, although differences were not statistically significant [143]. In a cross-sectional population-based study in Finland, frail persons were almost eight times more likely to have cognitive impairment, eight times more likely to have some kind of dementia, almost six times more likely to have VaD, and more than four times more likely to have AD than persons who were robust [144]. Furthermore, different studies have reported that physical frailty may be associated with incidence of AD [137], VaD [146, 147], non-AD dementias [148], and AD pathology in older persons with and without dementia [145] (Table 1). In the unadjusted model of the Three-City Study, being frail at baseline led to twice the cumulative risk of dementia at 4 years, although after adjusting for sociodemographic and health covariates frailty status did not remain a statistically significant predictor of dementia [23]. Findings from the Rush Memory and Aging Project raised the possibility that AD pathology may contribute to frailty or that frailty and AD pathology share a common pathogenesis [145]. In fact, physical frailty proximate to death was related to level of AD pathology on postmortem examination but was not related to the presence of cerebral infarcts or Lewy body disease. This association was similar in persons with and without dementia and was unchanged even after considering level of physical activity, various physical performance measures, and chronic diseases [145]. One longitudinal population-based study has examined the association of frailty or change in frailty with incident AD [137]. In fact, other findings from the Rush Memory and Aging Project on 820 subjects during a 3-year follow-up showed that the risk of developing AD was 2.5 times higher when physical frailty was present at baseline [137]. Some studies, however, have found associations with frailty and specific dementia subtypes [146148]. During a 3.5-year follow-up, in the ILSA, frailty syndrome was associated with a significantly increased risk of overall dementia and, in particular, VaD, whereas the risk of AD or other types of dementia did not significantly change in frail individuals compared with subjects without frailty syndrome [146]. A later analysis of the Three City Study confirmed the effect of frailty on incident VaD and overall dementia, but not on AD [147]. Data from the population-based Adult Changes in Thought (ACT) study also suggested an association between frailty and incident non-AD dementia (all dementias not classified as possible or probable AD), but not with AD [148]. Finally, some studies showed a reciprocal relationship indicating that cognitive impairment also may indicate the development of frailty [149, 150] (Table 1). In fact, a low MMSE score was independently associated with increased risk of physical frailty over a 10-year period in older Mexican Americans [149] and over a 2-year period in the same sample in adults older than age 75 years [150], suggesting that cognitive status may be an early marker for future risk of physical frailty (Table 1).

On the basis of this growing and extensive body of epidemiological evidence, an international consensus group comprised of investigators from the International Academy of Nutrition and Aging (IANA) and the International Association of Gerontology and Geriatrics (IAGG) recently convened in Toulouse, France, to establish a definition for “cognitive frailty” in older adults [125, 151]. “Cognitive frailty” is a heterogeneous clinical manifestation characterized by the simultaneous presence of both physical frailty and cognitive impairment [125]. In particular, the proposed criteria defining this novel age-related condition included presence of physical frailty and cognitive impairment, operationalized with the CHS phenotypic/biological model of frailty and with a Clinical Dementia rating Scale (CDR) of 0.5 (questionable dementia, a stage of the dementia continuum similar to MCI), and exclusion of concurrent AD dementia or other dementias [125]. The IANA/IAGG consensus group proposed a series of screening and diagnostic tools exploring and identifying multiple domains/causes of frailty, including cognitive and psychological status, in order to design effective interventions for cognitive frailty [125], a field that needs further development. In 2006, our group used the term “cognitive frailty” in the title of a review article on predementia syndrome and vascular risk factors, suggesting a particular state of cognitive vulnerability in MCI and other similar clinical entities exposed to vascular risk with a subsequent increased progression to overt dementia [152]. Therefore, cognitive frailty should be validated as a possible determinant of the principal health-related outcomes of the different frailty models, i.e., disability, hospitalizations, and mortality. Some longitudinal population-based studies investigated cognitive frailty models linked to increased disability and all-cause mortality [23, 127, 142, 153•] (Table 1). In the ILSA, frail, demented patients were at higher risk of all-cause mortality over 3- and 7-year follow-up periods, but not of disability [127]. Other two recent studies investigated the survival of patients with frailty and cognitive impairment. Findings from the Three-City Study suggested that cognitive impairment improved the predictive validity of the operational definition of physical frailty, increasing the risk to develop disability. On the contrary, risk of death also tended to be higher in cognitively impaired frail participants than in their non-frail counterparts without cognitive impairment, even if the results were not statistically significant [23]. In a small Italian study of 109 AD patients attending an outpatient geriatric clinic, 1 year after enrolment, frailty was an independent predictor of death after correction for age, sex, dependence in the basic activities of daily living (ADL), severity of cognitive impairment, and comorbidity [142]. Finally, more recently, in the H-EPESE, the cognitive frailty construct was operalizionated with the CHS frailty phenotype plus MMSE < 21 and followed as a possible determinant of all-cause mortality in a 10-year follow-up [153•]. As MMSE score declined over time, the percent of frail individuals increased and frailty and cognitive impairment were independent risk factors for mortality after controlling for all covariates. However, when both cognitive impairment and frailty (“cognitive frailty”) were added to the model, hazard ratio for individuals with cognitive impairment was no longer statistically significant [153•], suggesting that frailty may be a stronger predictor of mortality than cognitive impairment at least in this population of older Mexican Americans.

Nutrition and Frailty

Current epidemiological evidence supported the hypothesis that modifiable vascular, lifestyle-related, and metabolic factors also may be associated with the development of frailty syndrome and frailty components in later life [154156], opening new potential routes for the prevention of these disability-related conditions. In particular, among potentially modifiable risk factors, the impact of several nutritional factors on frailty and its components has been the subject of recent interest [22•, 154, 157, 158]. A more sedentary lifestyle, a reduction in metabolic cell mass and, consequently, lower energy expenditure and dietary intake are important contributors to the progression of frailty. A decline in intake is in turn associated with the risk of developing a suboptimal nutritional state or multiple micronutrient deficiencies [159]. In fact, undernutrition may be a major cause of frailty [160, 161], and older persons with protein energy undernutrition, a treatable condition, have poorer cognitive performance [162•, 163].

The transition from independence to disability in older adults is characterized by detectable changes in body composition and physical function. Epidemiologic studies have shown that weight loss, reduced caloric intake, and the reduced intake of specific nutrients are associated with such changes [155]. The mechanisms underlying these associations remain unclear, and different hypotheses have been suggested, including the reduction of the antioxidant effects of some nutrients. Among macronutrients, low protein intake was associated with higher prevalence of frailty among InCHIANTI study participants older than 65 years of age [157]. Consumption of specific micronutrients also has been associated with frailty-related outcomes. In the InCHIANTI study, higher dietary intake of vitamin C was significantly correlated with measures of knee extension and lower extremity performance [164], whereas the same study also reported an association between low intake of vitamin D, E, and C with prevalence of frailty [157]. Nutrient biomarkers have been extensively studied in association with physical function and frailty-related outcomes. An association between low circulating levels of vitamin E and the presence of frailty in the InCHIANTI sample also was found [158]. In the Women’s Health and Aging Study (WHAS), at baseline, frail women had significantly lower serum concentrations of vitamins D, E, and B6 and carotenoids compared with their non-frail peers [165, 166]. Moreover, non-frail women in the lowest quartiles of serum α-tocopherol, 25-hydroxyvitamin-D [25(OH)D], and carotenoids had an increased risk of becoming frail during the follow-up [165]. Furthemore, women in the lowest quartile of serum concentrations of vitamin B6, B12, and selenium had significantly higher risk of developing disability in ADL during a 3-year follow-up compared with women in the upper quartiles [167]. Finally, observational and clinical trials testing the relationship between vitamin D and physical performance provided mixed results [168, 169]. These suggestions also proposed to examine dietary patterns rather than single nutrients. In community-dwelling older adults, after a 6-year follow-up, higher adherence to a Mediterranean-style diet was associated with lower odds of developing frailty compared with those with lower adherence [170•]. A higher adherence to a Mediterranean-style diet at baseline was associated with a lower risk of low physical activity and low walking speed but not with feelings of exhaustion and poor muscle strength [170•]. Moreover, more recently, higher adherence to MeDi score was cross-sectionally associated with lower risk of being frail [171]. A cohort study conducted in French elderly community dwellers showed an inverse association between adherence to a Mediterranean-style diet and risk of disability in women, whereas no association was evidenced in men [172]. Among frailty components, high adherence to a Mediterranean-style diet was associated with a slower decline of mobility over 8 years of follow-up in community dwelling older persons [173], and walking speed over 8 years was faster among those with higher MeDi adherence at baseline [174], suggesting a long-term effect of this diet on mobility performance in older age.

Nutrition and physical exercise may be important and modifiable factors potentially affecting the frailty status of the older person [21•, 22•]. Some systematic reviews of home-based and group-based exercise interventions for frail older people showed that exercise have the potential to improve outcomes of mobility and functional ability [175, 176]. Furthermore, nutritional interventions might be able to address the impaired nutrition and weight loss of frailty. In fact, prefrailty and frailty were associated with lower nutritional status and higher food insufficiency in the participants older than age 60 years of the Third National Health and Nutrition Examination Survey (NHANES III) [177, 178]. Frailty also was associated with increased risk of malnutrition in men and women older than age 75 years [179]. An observational study of nutritional intervention with 400 kcal liquid meal, frail individuals showed lower hunger recuperation compared to non-frail individuals, 4 h after supplementation [180]. A recent meta-analysis of 12 studies on more than 1,800 older persons suggested that complete caloric nutritional supplements not only produced weight gain but also improved cognition [181•]. In frail nursing home residents, a nutrient- and energy-dense oral nutritional supplement not only improved nutritional status but also tended to improve quality of life [182]. On the other hand, one RCT that investigated the effects of exercise and nutritional supplementation in 100 frail elderly people in long-term care reported that such supplementation had no effect on muscle strength, gait speed, stair climbing, or physical activity [183]. However, more recently, one RCT among frail individuals aged 65 years and older with low socioeconomic status, showed that after 12 weeks of protein-energy supplementation, usual gait speed decreased by 1.0 % in the intervention compared with the control group, while there was no difference in hand-grip strength between the two groups [184]. The role of both nutrition and exercise was examined in only one pilot RCT conducted among Chinese men and women aged 65–79 years. The intervention groups received either nutritional consultation or problem-solving therapy (psychotherapy model) and the control groups had neither nutritional consultation nor problem-solving therapy. Primary outcome was improvement of the CHS phenotype of frailty by at least one category (from pre-frail to robust, or from frail to pre-frail or robust). The group that received nutritional consultation showed significantly higher improvement of the frailty phenotype compared to the control group after 3 months of intervention, but not at 6 and 12 months [185••].

Conclusions

Given the very limited therapeutic value of drugs currently used in the treatment of cognitive impairment and dementia, it results evident the necessity to potentially individualize new strategies able to prevent and to slow down the progression of MCI and dementia. Higher adherence to a Mediterranean-type diet was associated with cognitive decline although the MeDi combines several foods and nutrients already separately proposed as potential protective factors against dementia syndromes and late-life cognitive decline. Therefore, maintaining a healthy diet may have an impact on many possible risk factors for cognitive decline, and the models to follow seem to be the MeDi and DASH diets among healthy diets. On the basis of this evidence, the evaluation of the MeDi or DASH diets on cognitive outcomes seems of particular interest and recent prospective studies focusing on AD and dementia appeared to be really promising. Among different dietary patterns, higher adherence to the MeDi was associated with a reduced risk of cognitive impairment, MCI, and AD, as well as the transition from MCI to AD, and decreased all-causes mortality in AD patients. These findings suggested that adherence to the MeDi may affect not only the risk for AD, but also for MCI, probably influencing the evolution of cognitive performances over time and subsequent disease progression. However, while for the vascular hypothesis there was clear evidence about a protective role of DASH diet, and particularly MeDi and its nutrients in preventing all cardiovascular conditions linked to dementia, for the other possible mechanisms it was only possible to suggest hypothetical biological pathways taken into account the results from animal studies. Therefore, the lack of reproducibility in some results on the linked between healthier diet and cognitive decline and the speculative aspect of the biological pathways presented, suggested us to be cautious.

Other modifiable, age-related conditions linked to late-life cognitive decline may be important for the prevention of these devastating disorders. Among these conditions, frailty in older adults is a syndrome corresponding to a vulnerability to stressors and it tends to be considered as a major risk for adverse outcomes in older age. A recent and growing body of epidemiological evidence suggested that frailty may increase the risk of future cognitive decline and that cognitive impairment may increase the risk of frailty suggesting that cognition and frailty may interact in advancing aging. The etiology of frailty is multifactorial and besides hormonal and inflammatory processes, nutritional influences may be of major relevance. Nutritional interventions might be able to address the impaired nutrition and weight loss of frailty. There have been a limited number of RCTs investigating the role of nutrition on late-life cognitive disorders and frailty. There are difficulties in the design and conduction of RCTs in older persons, especially targeting complex conditions as frailty or AD and dementia. For example, if a change of dietary habits may play a major part on the prevention of frailty and late-life cognitive disorders, what is the role of genetic risk factors, or if these associations may be valid in populations with different dietary patterns? Other questions may address the underlying mechanisms and which is the most relevant component, among dietary micro- and macronutrients and their possible interactions. Answers to these questions will help us to better define the target populations for future preventive and therapeutic strategies also in older age. However, the reviewed epidemiological evidence clearly indicate the need to design and develop RCTs possibly addressing possible interactions in different populations with genetic factors and other possible confounders, and whether change in dietary patterns may protect against cognitive decline and AD, also through the nutritional prevention of frailty.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.

    Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3:186–91.

    PubMed  Google Scholar 

  2. 2.

    Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Santamato A, Ranieri M, et al. Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother. 2009;8:133–58.

    Google Scholar 

  3. 3.

    Peters R. The prevention of dementia. Int J Geriatr Psychiatry. 2009;24:452–8.

    PubMed  Google Scholar 

  4. 4.

    de la Torre JC. Alzheimer’s disease is incurable but preventable. J Alzheimers Dis. 2010;20:861–70.

    PubMed  Google Scholar 

  5. 5.

    Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, et al. Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother. 2011;11:677–708.

    PubMed  CAS  Google Scholar 

  6. 6.

    Panza F, Solfrizzi V, Logroscino G, Maggi S, Santamato A, Seripa D, et al. Current epidemiological approaches to the metabolic-cognitive syndrome. J Alzheimers Dis. 2012;30 Suppl 2:S31–75.

    PubMed  Google Scholar 

  7. 7.

    Richard E. Moll van Charante EP, van Gool WA. Vascular risk factors as treatment target to prevent cognitive decline. J Alzheimers Dis. 2012;32:733–40.

    PubMed  Google Scholar 

  8. 8.

    McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.

    PubMed Central  PubMed  Google Scholar 

  9. 9.

    Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.

    PubMed Central  PubMed  Google Scholar 

  10. 10.

    Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.

    PubMed Central  PubMed  Google Scholar 

  11. 11.

    Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804.

    PubMed Central  PubMed  CAS  Google Scholar 

  12. 12.•

    Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol. 2013;12:357–67. This prospective cohort study, applying a multidisciplinary approach including β-amyloid (Aβ) and structural imaging, constructed a model of the natural history of Aβ deposition and the sequence of changes in brain structure and cognition leading to sporadic Alzheimer’s disease (AD). According to their estimates, Aβ deposition is a slow process that extends for more than two decades.

    PubMed  CAS  Google Scholar 

  13. 13.

    Panza F, Solfrizzi V, Imbimbo BP, Tortelli R, Santamato A, Logroscino G. Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. Expert Rev Clin Immunol. 2014;10:405–19.

    PubMed  CAS  Google Scholar 

  14. 14.

    Panza F, Solfrizzi V, Frisardi V, Capurso C, D’Introno A, Colacicco AM, et al. Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging. 2009;26:537–55.

    PubMed  CAS  Google Scholar 

  15. 15.

    Panza F, Logroscino G, Imbimbo BP, Solfrizzi V. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease? Curr Opin Psychiatry. 2014;27:128–37.

    PubMed  Google Scholar 

  16. 16.

    Grant WB. Dietary links to Alzheimer's disease: 1999 Update. J Alzheimers Dis. 1999;1:197–201.

    PubMed  CAS  Google Scholar 

  17. 17.

    Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J Neural Transm. 2003;110:95–110.

    PubMed  CAS  Google Scholar 

  18. 18.

    Luchsinger JA, Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol. 2004;3:579–87.

    PubMed  Google Scholar 

  19. 19.

    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.

    PubMed  CAS  Google Scholar 

  20. 20.

    Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991–1001.

    PubMed  Google Scholar 

  21. 21.•

    Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–62. A recent and comprehensive review on frailty in older people, addressing the epidemiology, pathophysiology, assessment of frailty, and the development of interventions potentially effective for this clinical syndrome.

    PubMed  Google Scholar 

  22. 22.•

    Kelaiditi E, van Kan GA, Cesari M. Frailty: role of nutrition and exercise. Curr Opin Clin Nutr Metab Care. 2014;17:32–9. This is the most recent review on prevention of frailty in older people, comprehensively addressing the role of nutrition and exercise on frailty, supporting preventive strategies against disability in older person.

    PubMed  Google Scholar 

  23. 23.

    Avila-Funes JA, Amieva H, Barberger-Gateau P, Le Goff M, Raoux N, Ritchie K, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the Three-City Study. J Am Geriatr Soc. 2009;57:453–61.

    PubMed  Google Scholar 

  24. 24.

    Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, Hébert R, et al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: Report from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci. 2004;59A:1310–7.

    Google Scholar 

  25. 25.

    Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173:489–95.

    Google Scholar 

  26. 26.

    Eeles EM, White SV, O’Mahony SM, Bayer AJ, Hubbard RE. The impact of frailty and delirium on mortality in older inpatients. Age Ageing. 2012;41:412–6.

    PubMed  Google Scholar 

  27. 27.

    Panza F, Solfrizzi V, Frisardi V, Maggi S, Sancarlo D, Addante F, et al. Different models of frailty in predementia and dementia syndromes. J Nutr Health Aging. 2011;15:711–9.

    PubMed  CAS  Google Scholar 

  28. 28.

    Harrison FE. A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease. J Alzheimers Dis. 2012;29:711–26.

    PubMed Central  PubMed  CAS  Google Scholar 

  29. 29.

    Viña J, Lloret A, Giraldo E, Badia MC, Alonso MD. Antioxidant pathways in Alzheimer's disease: possibilities of intervention. Curr Pharm Des. 2011;17:3861–4.

    PubMed  Google Scholar 

  30. 30.

    Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 2007;64:86–92.

    PubMed  Google Scholar 

  31. 31.

    Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother. 2010;10:729–45.

    PubMed  CAS  Google Scholar 

  32. 32.

    Hu N, Yu JT, Tan L, Wang YL, Sun L, Tan L. Nutrition and the risk of Alzheimer's disease. Biomed Res Int. 2013;2013:524820.

    PubMed Central  PubMed  Google Scholar 

  33. 33.

    Shah R. The role of nutrition and diet in Alzheimer’s disease: a systematic review. J Am Med Dir Assoc. 2013;14:398–402.

    PubMed  Google Scholar 

  34. 34.

    Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol. 2012;69:836–41.

    PubMed Central  PubMed  Google Scholar 

  35. 35.

    Wald DS, Kasturiratne A, Simmonds M. Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med. 2010;123:522–7.

    PubMed  CAS  Google Scholar 

  36. 36.

    Presse N, Belleville S, Gaudreau P, Greenwood CE, Kergoat MJ, Morais JA, et al. Vitamin K status and cognitive function in healthy older adults. Neurobiol Aging. 2013;34:2777–83.

    PubMed  CAS  Google Scholar 

  37. 37.

    Coley N, Andrieu S, Gardette V, Gillette-Guyonnet S, Sanz C, Vellas B, et al. Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev. 2008;30:35–66.

    PubMed  Google Scholar 

  38. 38.

    Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, et al. Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimers Dis. 2010;22:715–40.

    PubMed  CAS  Google Scholar 

  39. 39.

    Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, et al. Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Ageing Res Rev. 2010;9:184–99.

    PubMed  CAS  Google Scholar 

  40. 40.

    Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res. 2009;48:239–56.

    PubMed  CAS  Google Scholar 

  41. 41.

    Solfrizzi V, Colacicco AM, D’Introno A, Capurso C, Torres F, Rizzo C, et al. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging. 2006;27:1694–704.

    PubMed  CAS  Google Scholar 

  42. 42.

    Naqvi AZ, Harty B, Mukamal KJ, Stoddard AM, Vitolins M, Dunn JE. Monounsaturated, trans, and saturated Fatty acids and cognitive decline in women. J Am Geriatr Soc. 2011;59:837–43.

    PubMed Central  PubMed  Google Scholar 

  43. 43.

    Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009;5:140–52.

    PubMed  CAS  Google Scholar 

  44. 44.

    van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, Beekman AT, et al. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2008;88:706–13.

    PubMed  Google Scholar 

  45. 45.

    van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology. 2008;71:430–8.

    PubMed  Google Scholar 

  46. 46.

    Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304:1903–11.

    PubMed Central  PubMed  CAS  Google Scholar 

  47. 47.••

    Martínez-Lapiscina EH, Clavero P, Toledo E, San Julián B, Sanchez-Tainta A, Corella D, et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging. 2013;17:544–52. This key paper suggested that Mediterranean diet supplemented with extra virgin olive oil (1 l/week) for 6.5 years improved cognitive performance, while a supplement of mixed nuts (30 g/ day) had no effect. Persons taking extra virgin olive oil were less likely to develop mild cognitive impairment.

    PubMed  Google Scholar 

  48. 48.

    Friedland RP. Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? Arch Neurol. 2003;60:923–4.

    PubMed  Google Scholar 

  49. 49.•

    Crichton GE, Bryan J, Murphy KJ, Buckley J. Review of dairy consumption and cognitive performance in adults: findings and methodological issues. Dement Geriatr Cogn Disord. 2010;30:352–61. Comprehensive and unique review on the possible association between dairy intake and cognitive functioning.

    PubMed  Google Scholar 

  50. 50.

    Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G. Association between dementia and midlife risk factors: the radiation effects research foundation adult health study. J Am Geriatr Soc. 2003;51:410–4.

    PubMed  Google Scholar 

  51. 51.

    Kliem KE, Givens DI. Dairy products in the food chain: their impact on health. Annu Rev Food Sci Technol. 2011;2:21–36.

    PubMed  Google Scholar 

  52. 52.

    Kerola T, Kettunen R, Nieminen T. The complex interplay of cardiovascular system and cognition: how to predict dementia in the elderly? Int J Cardiol. 2011;150:123–9.

    PubMed  Google Scholar 

  53. 53.

    Henderson ST. High carbohydrate diets and Alzheimer's disease. Med Hypotheses. 2004;62:689–700.

    PubMed  CAS  Google Scholar 

  54. 54.

    Seneff S, Wainwright G, Mascitelli L. Nutrition and Alzheimer's disease: the detrimental role of a high carbohydrate diet. Eur J Intern Med. 2011;22:134–40.

    PubMed  CAS  Google Scholar 

  55. 55.

    Luchsinger JA, Tang MX, Mayeux R. Glycemic load and risk of Alzheimer's disease. J Nutr Health Aging. 2007;11:238–41.

    PubMed  CAS  Google Scholar 

  56. 56.

    Loef M, Walach H. Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies. J Nutr Health Aging. 2012;16:626–30.

    PubMed  CAS  Google Scholar 

  57. 57.

    Barranco Quintana JL, Allam MF, Serrano Del Castillo A, Fernandez-Crehuet NR. Alzheimer’s disease and coffee: a quantitative review. Neurol Res. 2007;29:91–5.

    PubMed  Google Scholar 

  58. 58.

    Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis. 2010;20 Suppl 1:S187–204.

    PubMed  Google Scholar 

  59. 59.•

    Arab L, Khan F, Lam H. Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline. Adv Nutr. 2013;4:115–22. A recent and in depth review of tea, coffee, and caffeine consumption and cognition.

    PubMed Central  PubMed  CAS  Google Scholar 

  60. 60.

    Panza F, Frisardi V, Seripa D, Logroscino G, Santamato A, Imbimbo BP, et al. Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry. 2012;27:1218–38.

    PubMed  Google Scholar 

  61. 61.

    Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly. a systematic review. Age Ageing. 2008;37:505–12.

    PubMed  Google Scholar 

  62. 62.

    Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009;17:542–55.

    PubMed  Google Scholar 

  63. 63.

    Neafsey EJ, Collins MA. Moderate alcohol consumption and cognitive risk. Neuropsychiatr Dis Treat. 2011;7:465–84.

    PubMed Central  PubMed  Google Scholar 

  64. 64.

    Luchsinger JA, Noble JM, Scarmeas N. Diet and Alzheimer's disease. Curr Neurol Neurosci Rep. 2007;7:366–72.

    PubMed  CAS  Google Scholar 

  65. 65.

    Samieri C, Jutand MA, Féart C, Capuron L, Letenneur L, Barberger-Gateau P. Dietary patterns derived by hybrid clustering method in older people: association with cognition, mood, and self-rated health. J Am Diet Assoc. 2008;108:1461–71.

    PubMed  Google Scholar 

  66. 66.

    Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease? J Alzheimers Dis. 2010;20:795–801.

    PubMed  Google Scholar 

  67. 67.

    Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife healthy-diet index and late-life dementia and Alzheimer's disease. Dement Geriatr Cogn Dis Extra. 2011;1:103–12.

    PubMed Central  PubMed  Google Scholar 

  68. 68.•

    Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC, et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology. 2013;24:479–89. A comprehensive and systematic review synthesizing the available evidence on the association between adherence to Mediterranean diet and cognitive function or dementia.

    PubMed  Google Scholar 

  69. 69.

    Kesse-Guyot E, Andreeva VA, Jeandel C, Ferry M, Hercberg S, Galan P. A healthy dietary pattern at midlife is associated with subsequent cognitive performance. J Nutr. 2012;142:909–15.

    PubMed  CAS  Google Scholar 

  70. 70.

    Allès B, Samieri C, Féart C, Jutand MA, Laurin D, Barberger-Gateau P. Dietary patterns: a novel approach to examine the link between nutrition and cognitive function in older individuals. Nutr Res Rev. 2012;25:207–22.

    PubMed  Google Scholar 

  71. 71.•

    Ozawa M, Ninomiya T, Ohara T, Doi Y, Uchida K, Shirota T, et al. Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama Study. Am J Clin Nutr. 2013;97:1076–82. A Japanese population-based study suggesting that a higher adherence to a Japanese-style diet with a dietary pattern characterized by a high intake of soybeans and soybean products, vegetables, algae, and milk and dairy products and a low intake of rice may be associated with reduced risk of dementia.

    PubMed  CAS  Google Scholar 

  72. 72.•

    Tangney CC. DASH and Mediterranean-type dietary patterns to maintain cognitive health. Curr Nutr Rep. 2014;3:51–61. Complete and very updated review on the principal dietary patterns linked to the protection against dementia and late-life cognitive decline.

    CAS  Google Scholar 

  73. 73.

    Solfrizzi V, Panza F. Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead? J Alzheimers Dis. 2014;39:283–6.

    PubMed  Google Scholar 

  74. 74.

    Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13:3–9.

    PubMed  CAS  Google Scholar 

  75. 75.

    Hooijmans CR, Rutters F, Dederen PJ, et al. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol Dis. 2007;28:16–29.

    PubMed  CAS  Google Scholar 

  76. 76.

    Studzinski CM, Li F, Bruce-Keller AJ, et al. Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice. J Neurochem. 2009;108:860–6.

    PubMed Central  PubMed  CAS  Google Scholar 

  77. 77.

    Gustaw-Rothenberg K. Dietary patterns associated with Alzheimer's disease: population based study. Int J Environ Res Public Health. 2009;6:1335–40.

    PubMed Central  PubMed  Google Scholar 

  78. 78.

    Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. Food combination and Alzheimer disease risk: a protective diet. Arch Neurol. 2010;67:699–706.

    PubMed Central  PubMed  Google Scholar 

  79. 79.

    Akbaraly TN, Singh-Manoux A, Marmot MG, Brunner EJ. Education attenuates the association between dietary patterns and cognition. Dement Geriatr Cogn Disord. 2009;27:147–54.

    PubMed Central  PubMed  Google Scholar 

  80. 80.

    Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296–308.

    PubMed  CAS  Google Scholar 

  81. 81.

    Sacks FM, Campos H. Dietary therapy in hypertension. N Engl J Med. 2010;362:2102–12.

    Google Scholar 

  82. 82.••

    Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, et al. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension. 2010;55:1331–8. A trial designed to improve cardiovascular outcomes in a high-risk U.S. population sample in which repeated cognitive testing has occurred over a short 4-month period. Cognitive improvements were noted in both Dietary Approaches to Stop Hypertension (DASH) active treatments; a DASH dietary modification or a DASH dietary modification plus weight loss against usual care.

    PubMed Central  PubMed  CAS  Google Scholar 

  83. 83.

    Norton MC, Dew J, Smith H, Fauth E, Piercy KW, Breitner JC, et al. Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache County study. J Am Geriatr Soc. 2012;60:405–12.

    PubMed Central  PubMed  Google Scholar 

  84. 84.••

    Wengreen H, Munger RG, Cutler A, Quach A, Bowles A, Corcoran C, et al. Prospective study of dietary approaches to stop hypertension–and Mediterranean-style dietary patterns and age-related cognitive change: the cache county study on memory, health and aging. Am J Clin Nutr. 2013;98:1272–81. Dietary Approaches to Stop Hypertension and Mediterranean diet scores were assessed in relation to repeated cognitive measures. Higher scores of each pattern were consistently associated higher cognitive function over an 11-year period in a U.S. cohort of 3,861 men and women.

    Google Scholar 

  85. 85.

    Feart C, Samieri C, Barberger-Gateau P. Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care. 2010;13:14–8.

    PubMed Central  PubMed  CAS  Google Scholar 

  86. 86.

    Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet and stroke, cognitive impairment, depression: a meta-analysis. Ann Neurol. 2013;74:580–91.

    PubMed  Google Scholar 

  87. 87.

    Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39:271–82.

    PubMed  Google Scholar 

  88. 88.

    McMillan L, Owen L, Kras M, Scholey A. Behavioural effects of a 10-day Mediterranean diet. Results from a pilot study evaluating mood and cognitive performance. Appetite. 2011;56:143–7.

    PubMed  Google Scholar 

  89. 89.••

    Martínez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvadó J, San Julián B, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry. 2013;84:1318–25. This key paper was the first long-term prevention randomized trial that compared two interventions with Mediterranean diet (MeDi) versus a low-fat diet. An intervention with MeDi with supplementation with either extra-virgin olive oil or nuts appeared to improve cognition compared with a low-fat diet in a 6.5-year follow-up.

    PubMed  Google Scholar 

  90. 90.•

    Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment-A review of the evidence and causal mechanisms. Ageing Res Rev. 2013;12:840–51. A very comprehensive review on the relationship between frailty and cognitive impairment, also focusing on the possible mechanisms behind this association.

    PubMed  Google Scholar 

  91. 91.

    Rockwood K. Frailty and its definition: a worthy challenge. J Am Geriatr Soc. 2005;53:1069–70.

    PubMed  Google Scholar 

  92. 92.

    Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med. 1992;8:1–17.

    PubMed  CAS  Google Scholar 

  93. 93.

    Hamerman D. Toward an understanding of frailty. Ann Intern Med. 1999;130:945–50.

    PubMed  CAS  Google Scholar 

  94. 94.

    Rockwood K, Hogan DB, MacKnight C. Conceptualisation and measurement of frailty in elderly people. Drugs Aging. 2000;17:295–302.

    PubMed  CAS  Google Scholar 

  95. 95.

    Markle-Reid M, Browne G. Conceptualizations of frailty in relation to older adults. J Adv Nurs. 2003;44:58–68.

    PubMed  Google Scholar 

  96. 96.

    Hogan DB, MacKnight C, Bergman H. Models, definitions, and criteria of frailty. Aging Clin Exp Res. 2003;15:1–29.

    PubMed  Google Scholar 

  97. 97.

    Levers MJ, Estabrooks CA, Ross Kerr JC. Factors contributing to frailty: literature review. J Adv Nurs. 2006;56:282–91.

    PubMed  Google Scholar 

  98. 98.

    Schuurmans H, Steverink N, Lindenberg S, Frieswijk N, Slaets JP. Old or frail: what tells us more? J Gerontol A Biol Sci Med Sci. 2004;59:M962–5.

    PubMed  Google Scholar 

  99. 99.

    Gobbens RJ, Luijkx KG, Wijnen-Sponselee MT, Schols JM. In search of an integral conceptual definition of frailty: opinions of experts. J Am Med Dir Assoc. 2010;11:338–43.

    PubMed  Google Scholar 

  100. 100.

    Sourial N, Wolfson C, Bergman H, Zhu B, Karunananthan S, Quail J, et al. A correspondence analysis revealed frailty deficits aggregate and are multidimensional. J Clin Epidemiol. 2010;63:647–54.

    PubMed Central  PubMed  Google Scholar 

  101. 101.

    Sourial N, Bergman H, Karunananthan S, Wolfson C, Guralnik J, Payette H, et al. Contribution of frailty markers in explaining differences among individuals in five samples of older persons. J Gerontol A Biol Sci Med Sci. 2012;67:1197–204.

    PubMed Central  PubMed  Google Scholar 

  102. 102.

    de Vries NM, Staal JB, van Ravensberg CD, Hobbelen JS, Olde Rikkert MG, Nijhuis-van der Sanden MW. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev. 2011;10:104–14.

    PubMed  Google Scholar 

  103. 103.

    Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving concept. Can Med Assoc J. 1994;150:489–95.

    CAS  Google Scholar 

  104. 104.

    Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722–7.

    PubMed  Google Scholar 

  105. 105.•

    Rodríguez-Mañas L, Féart C, Mann G, Viña J, Chatterji S, Chodzko-Zajko W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68:62–7. A modified Delphi process was used to attempt to achieve a consensus on the operational definition of frailty.

    PubMed Central  PubMed  Google Scholar 

  106. 106.

    Studenski S, Hayes RP, Leibowitz RQ, Bode R, Lavery L, Walston J, et al. Clinical Global Impression of Change in Physical Frailty: development of a measure based on clinical judgment. J Am Geriatr Soc. 2004;52:1560–6.

    PubMed  Google Scholar 

  107. 107.

    Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm issues and controversies. J Gerontol A Biol Sci Med Sci. 2007;62:731–7.

    PubMed Central  PubMed  Google Scholar 

  108. 108.

    Fulop T, Larbi A, Witkowski JM, McElhaney J, Loeb M, Mitnitski A, et al. Aging, frailty and age-related diseases. Biogerontology. 2010;11:547–663.

    Google Scholar 

  109. 109.

    Jones DM, Song X, Rockwood K. Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc. 2004;52:1929–33.

    PubMed  Google Scholar 

  110. 110.

    Jones D, Song X, Mitnitski A, Rockwood K. Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians. Aging Clin Exp Res. 2005;17:465–71.

    PubMed  Google Scholar 

  111. 111.

    Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62:738–43.

    PubMed  Google Scholar 

  112. 112.

    Cigolle CT, Ofstedal MB, Tian Z, Blaum CS. Comparing models of frailty: the health and retirement study. J Am Geriatr Soc. 2009;57:830–9.

    PubMed  Google Scholar 

  113. 113.

    Pilotto A, Rengo F, Marchionni N, Sancarlo D, Fontana A, Panza F, et al. Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients. PLoS One. 2012;7:e29090.

    PubMed Central  PubMed  CAS  Google Scholar 

  114. 114.

    Rockwood K, Abeysundera MJ, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc. 2007;8:595–603.

    PubMed  Google Scholar 

  115. 115.

    Armstrong JJ, Stolee P, Hirdes JP, Poss JW. Examining three frailty conceptualizations in their ability to predict negative outcomes for home-care clients. Age Ageing. 2010;39:755–8.

    PubMed  Google Scholar 

  116. 116.

    Mitnitski A, Fallah N, Rockwood K. A multistate model of cognitive dynamics in relation to frailty in older adults. Ann Epidemiol. 2011;21:507–16.

    PubMed  Google Scholar 

  117. 117.

    Mitnitski A, Fallah N, Rockwood MR, Rockwood K. Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures. J Nutr Health Aging. 2011;15:863–7.

    PubMed  CAS  Google Scholar 

  118. 118.

    Song X, Mitnitski A, Rockwood K. Nontraditional risk factors combine to predict Alzheimer disease and dementia. Neurology. 2011;77:227–34.

    PubMed Central  PubMed  Google Scholar 

  119. 119.

    Pilotto A, Sancarlo D, Panza F, Paris F, D'Onofrio G, Cascavilla L, et al. The Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimers Dis. 2009;18:191–9.

    PubMed Central  PubMed  Google Scholar 

  120. 120.

    Dramé M, Novella JL, Jolly D, Lanièce I, Somme D, Heitz D, et al. Rapid cognitive decline, one-year institutional admission and one-year mortality: analysis of the ability to predict and inter-tool agreement of four validated clinical frailty indexes in the SAFEs cohort. J Nutr Health Aging. 2011;15:699–705.

    PubMed  Google Scholar 

  121. 121.

    Doba N, Tokuda Y, Goldstein NE, Kushiro T, Hinohara S. A pilot trial to predict frailty syndrome: the Japanese Health Research Volunteer Study. Exp Gerontol. 2012;47:638–43.

    PubMed  Google Scholar 

  122. 122.••

    Kelaiditi E, Cesari M, Canevelli M, van Kan GA, Ousset PJ, Gillette-Guyonnet S, et al. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging. 2013;17:726–34. An international consensus group comprised of investigators from the International Academy of Nutrition and Aging (IANA) and the International Association of Gerontology and Geriatrics (IAGG) proposed a definition for “cognitive frailty” in older adults.

    PubMed  CAS  Google Scholar 

  123. 123.

    Jacobs JM, Cohen A, Ein-Mor E, Maaravi Y, Stessman J. Frailty, cognitive impairment and mortality among the oldest old. J Nutr Health Aging. 2011;15:678–82.

    PubMed  CAS  Google Scholar 

  124. 124.

    Ávila-Funes JA, Pina-Escudero SD, Aguilar-Navarro S, Gutierrez-Robledo LM, Ruiz-Arregui L, Amieva H. Cognitive impairment and low physical activity are the components of frailty more strongly associated with disability. J Nutr Health Aging. 2011;15:683–9.

    PubMed  Google Scholar 

  125. 125.

    Ní Mhaoláin AM, Gallagher D, Crosby L, Ryan D, Lacey L, Coen R, et al. Correlates of frailty in Alzheimer's disease and mild cognitive impairment. Age Ageing. 2011;40:630–3.

    PubMed  Google Scholar 

  126. 126.

    O'Halloran AM, Fan CW, Kenny RA, Pénard N, Galli A, Robertson IH. Variability in sustained attention and risk of frailty. J Am Geriatr Soc. 2011;59:2390–2.

    PubMed  Google Scholar 

  127. 127.

    Solfrizzi V, Scafato E, Frisardi V, Sancarlo D, Seripa D, Logroscino G, et al. Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. Age (Dordr). 2012;34:507–17.

    Google Scholar 

  128. 128.

    Jürschik P, Nunin C, Botigué T, Escobar MA, Lavedán A, Viladrosa M. Prevalence of frailty and factors associated with frailty in the elderly population of Lleida, Spain: the FRALLE survey. Arch Gerontol Geriatr. 2012;55:625–31.

    PubMed  Google Scholar 

  129. 129.

    Macuco CR, Batistoni SS, Lopes A, Cachioni M, da Silva Falcão DV, Neri AL, et al. Mini-Mental State Examination performance in frail, pre-frail, and non-frail community dwelling older adults in Ermelino Matarazzo, São Paulo, Brazil. Int Psychogeriatr. 2012;24:1725–31.

    PubMed  Google Scholar 

  130. 130.

    Yassuda MS, Lopes A, Cachioni M, Falcao DV, Batistoni SS, Guimaraes VV, et al. Frailty criteria and cognitive performance are related: data from the FIBRA study in Ermelino Matarazzo, São Paulo, Brazil. J Nutr Health Aging. 2012;16:55–61.

    PubMed  CAS  Google Scholar 

  131. 131.

    Langlois F, Vu TT, Kergoat MJ, Chassé K, Dupuis G, Bherer L. The multiple dimensions of frailty: physical capacity, cognition, and quality of life. Int Psychogeriatr. 2012;24:1429–36.

    PubMed  Google Scholar 

  132. 132.

    Shimada H, Makizako H, Doi T, Yoshida D, Tsutsumimoto K, Anan Y, et al. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. J Am Med Dir Assoc. 2013;14:518–24.

    PubMed  Google Scholar 

  133. 133.

    Han ES, Lee Y, Kim J. Association of cognitive impairment with frailty in community-dwelling older adults. Int Psychogeriatr. 2014;26:155–63.

    PubMed  Google Scholar 

  134. 134.

    Ottenbacher KJ, Ostir GV, Peek MK, Snih SA, Raji MA, Markides KS. Frailty in older Mexican Americans. J Am Geriatr Soc. 2005;53:1524–31.

    PubMed Central  PubMed  Google Scholar 

  135. 135.

    Gill TM, Williams CS, Richardson ED, Tinetti ME. Impairments in physical performance and cognitive status as predisposing factors for functional dependence among nondisabled older persons. J Gerontol A Biol Sci Med Sci. 1996;51A:M283–8.

    Google Scholar 

  136. 136.

    Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 1998;53B:S9–16.

    Google Scholar 

  137. 137.

    Buchman AS, Boyle PA, Wilson RS, Tang Y, Bennett DA. Frailty is associated with incident Alzheimer’s disease and cognitive decline in the elderly. Psychosom Med. 2007;69:483–9.

    PubMed  Google Scholar 

  138. 138.

    Samper-Ternent R, Al Snih S, Raji MA, Markides KS, Ottenbacher KJ. Relationship between frailty and cognitive decline in older Mexican Americans. J Am Geriatr Soc. 2008;56:1845–52.

    PubMed Central  PubMed  Google Scholar 

  139. 139.

    Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc. 2010;58:248–55.

    PubMed Central  PubMed  Google Scholar 

  140. 140.

    Sarkisian CA, Gruenewald TL, John Boscardin W, Seeman TE. Preliminary evidence for subdimensions of geriatric frailty: the MacArthur study of successful aging. J Am Geriatr Soc. 2008;56:2292–7.

    PubMed Central  PubMed  Google Scholar 

  141. 141.

    Auyeung TW, Lee JS, Kwok T, Woo J. Physical frailty predicts future cognitive decline - a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging. 2011;15:690–4.

    PubMed  CAS  Google Scholar 

  142. 142.

    Bilotta C, Bergamaschini L, Nicolini P, Casè A, Pina G, Rossi SV, et al. Frailty syndrome diagnosed according to the Study of Osteoporotic Fractures criteria and mortality in older outpatients suffering from Alzheimer's disease: a one-year prospective cohort study. Aging Ment Health. 2012;16:273–80.

    PubMed  Google Scholar 

  143. 143.

    Bilotta C, Nicolini P, Casè A, Pina G, Rossi S, Vergani C. Frailty syndrome diagnosed according to the Study of Osteoporotic Fractures (SOF) criteria and adverse health outcomes among community-dwelling older outpatients in Italy. A one-year prospective cohort study. Arch Gerontol Geriatr. 2012;54:e23–8.

    PubMed  Google Scholar 

  144. 144.

    Kulmala J, Nykänen I, Mänty M, Hartikainen S. Association between Frailty and Dementia: a population-based study. Gerontology. 2014;60:16–21.

    PubMed  Google Scholar 

  145. 145.

    Buchman AS, Schneider JA, Leurgans S, Bennett DA. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology. 2008;71:499–504.

    PubMed Central  PubMed  Google Scholar 

  146. 146.

    Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Maggi S, et al. Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging. Alzheimers Dement. 2013;9:113–22.

    PubMed  Google Scholar 

  147. 147.

    Avila-Funes JA, Carcaillon L, Helmer C, Carrière I, Ritchie K, Rouaud O, et al. Is frailty a prodromal stage of vascular dementia? Results from the Three-City Study. J Am Geriatr Soc. 2012;60:1708–12.

    PubMed  Google Scholar 

  148. 148.

    Gray SL, Anderson ML, Hubbard RA, LaCroix A, Crane PK, McCormick W, et al. Frailty and incident dementia. J Gerontol A Biol Sci Med Sci. 2013;68:1083–90.

    PubMed  Google Scholar 

  149. 149.

    Raji MA, Al Snih S, Ostir GV, Markides KS, Ottenbacher KJ. Cognitive status and future risk of frailty in older Mexican Americans. J Gerontol A Biol Sci Med Sci. 2010;65:1228–34.

    PubMed  Google Scholar 

  150. 150.

    Aranda MP, Ray LA, Snih SA, Ottenbacher KJ, Markides KS. The protective effect of neighborhood composition on increasing frailty among older Mexican Americans: a barrio advantage? J Aging Health. 2011;23:1189–217.

    PubMed Central  PubMed  Google Scholar 

  151. 151.

    Woods AJ, Cohen RA, Pahor M. Cognitive frailty: frontiers and challenges. J Nutr Health Aging. 2013;17:741–3.

    PubMed  CAS  Google Scholar 

  152. 152.

    Panza F, D'Introno A, Colacicco AM, Capurso C, Parigi AD, Capurso SA, et al. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging. 2006;27:933–40.

    PubMed  CAS  Google Scholar 

  153. 153.•

    Cano C, Samper-Ternent R, Al Snih S, Markides K, Ottenbacher KJ. Frailty and cognitive impairment as predictors of mortality in older Mexican Americans. J Nutr Health Aging. 2012;16:142–7. A population-based study with a 10-year follow-up investigating a cognitive frailty model linked to increased all-cause mortality in older adults.

    PubMed Central  PubMed  CAS  Google Scholar 

  154. 154.

    Milaneschi Y, Tanaka T, Ferrucci L. Nutritional determinants of mobility. Curr Opin Clin Nutr Metab Care. 2010;13:625–9.

    PubMed Central  PubMed  CAS  Google Scholar 

  155. 155.

    Inzitari M, Doets E, Bartali B, Benetou V, Di Bari M, Di Visser M. International Association Of Gerontology And Geriatrics (IAGG) Task Force For Nutrition In The Elderly. Nutrition in the age-related disablement process. J Nutr Health Aging. 2011;15:599–604.

    PubMed  CAS  Google Scholar 

  156. 156.

    Lee JS, Auyeung TW, Leung J, Kwok T, Leung PC, Woo J. Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass. J Nutr Health Aging. 2011;15:857–62.

    PubMed  CAS  Google Scholar 

  157. 157.

    Bartali B, Frongillo EA, Bandinelli S, Lauretani F, Semba RD, Fried LP, et al. Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci. 2006;61:589–93.

    PubMed Central  PubMed  Google Scholar 

  158. 158.

    Ble A, Cherubini A, Volpato S, Bartali B, Walston JD, Windham BG, et al. Lower plasma vitamin E levels are associated with the frailty syndrome: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2006;61:278–83.

    PubMed  Google Scholar 

  159. 159.

    de Jong N, Chin A, Paw MJ, de Groot LC, de Graaf C, Kok FJ, et al. Functional biochemical and nutrient indices in frail elderly people are partly affected by dietary supplements but not by exercise. J Nutr. 1999;129:2028–36.

    PubMed  Google Scholar 

  160. 160.

    Morley JE. Developing novel therapeutic approaches to frailty. Curr Pharm Des. 2009;15:3384–95.

    PubMed  CAS  Google Scholar 

  161. 161.

    Cesari M. Perspective: protein supplementation against sarcopenia and frailty – future perspectives from novel data. J Am Med Dir Assoc. 2013;14:62–3.

    PubMed  Google Scholar 

  162. 162.•

    Tamura BK, Bell CL, Masaki KH, Amella EJ. Factors associated with weight loss, low BMI, and malnutrition among nursing home patients: A systematic review of the literature. J Am Med Dir Assoc. 2013;14:649–55. A systematic review on factors associated with weight loss and poor nutrition in long term care to target high-risk institutionalized patients.

    PubMed  Google Scholar 

  163. 163.

    Morley JE. Cognition and nutrition. Curr Opin Clin Nutr Metab Care. 2014;17:1–4.

    PubMed  CAS  Google Scholar 

  164. 164.

    Cesari M, Pahor M, Bartali B, Cherubini A, Penninx BW, Williams GR, et al. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr. 2004;79:289–94.

    PubMed  CAS  Google Scholar 

  165. 165.

    Semba RD, Bartali B, Zhou J, Blaum C, Ko CW, Fried LP. Low serum micronutrient concentrations predict frailty among older women living in the community. J Gerontol A Biol Sci Med Sci. 2006;61:594–9.

    PubMed  Google Scholar 

  166. 166.

    Michelon E, Blaum C, Semba RD, Xue QL, Ricks MO, Fried LP. Vitamin and carotenoid status in older women: associations with the frailty syndrome. J Gerontol A Biol Sci Med Sci. 2006;61:600–7.

    PubMed  Google Scholar 

  167. 167.

    Bartali B, Semba RD, Frongillo EA, Varadhan R, Ricks MO, Blaum CS, et al. Low micronutrient levels as a predictor of incident disability in older women. Arch Intern Med. 2006;166:2335–40.

    PubMed Central  PubMed  CAS  Google Scholar 

  168. 168.

    Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O. Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging. 2009;13:893–8.

    PubMed  CAS  Google Scholar 

  169. 169.

    Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.

    PubMed Central  PubMed  CAS  Google Scholar 

  170. 170.•

    Talegawkar SA, Bandinelli S, Bandeen-Roche K, Chen P, Milaneschi Y, Tanaka T, et al. A higher adherence to a mediterranean-style diet is inversely associated with the development of frailty in community-dwelling elderly men and women. J Nutr. 2012;142:2161–6. A population-based study with a 6-year follow-up showing that higher adherence to a Mediterranean-style diet at baseline was associated with a lower risk for frailty. Among frailty components, a higher adherence to a Mediterranean-style diet at baseline was associated with lower odds of low physical activity as well as low walking speed.

    PubMed Central  PubMed  CAS  Google Scholar 

  171. 171.

    Bollwein J, Diekmann R, Kaiser MJ, et al. Dietary quality is related to frailty in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2013;68:483–9.

    PubMed  Google Scholar 

  172. 172.

    Féart C, Pérès K, Samieri C, Letenneur L, Dartigues JF, Barberger-Gateau P. Adherence to a Mediterranean diet and onset of disability in older persons. Eur J Epidemiol. 2011;26:747–56.

    PubMed  Google Scholar 

  173. 173.

    Milaneschi Y, Bandinelli S, Corsi AM, Lauretani F, Paolisso G, Dominguez LJ, et al. Mediterranean diet and mobility decline in older persons. Exp Gerontol. 2011;46:303–8.

    PubMed Central  PubMed  Google Scholar 

  174. 174.

    Shahar DR, Houston DK, Hue TF, Lee JS, Sahyoun NR, Tylavsky FA, et al. Adherence to mediterranean diet and decline in walking speed over 8 years in community-dwelling older adults. J Am Geriatr Soc. 2012;60:1881–8.

    PubMed Central  PubMed  Google Scholar 

  175. 175.

    de Vries NM, van Ravensberg CD, Hobbelen JS, Olde Rikkert MG, Staal JB, Nijhuis-van der Sanden MW. Effects of physical exercise therapy on mobility, physical functioning, physical activity and quality of life in community-dwelling older adults with impaired mobility, physical disability and/or multi-morbidity: a meta-analysis. Ageing Res Rev. 2012;11:136–49.

    PubMed  Google Scholar 

  176. 176.

    Clegg A, Barber S, Young J, Forster A, Iliffe S. Do home-based exercise interventions improve outcomes for frail older people? Findings from a systematic review. Rev Clin Gerontol. 2012;22:68–78.

    Google Scholar 

  177. 177.

    Smit E, Crespo CJ, Michael Y, Ramirez-Marrero FA, Brodowicz GR, Bartlett S, et al. The effect of vitamin D and frailty on mortality among noninstitutionalized US older adults. Eur J Clin Nutr. 2012;66:1024–8.

    PubMed  CAS  Google Scholar 

  178. 178.

    Smit E, Winters-Stone KM, Loprinzi PD, Tang AM, Crespo CJ. Lower nutritional status and higher food insufficiency in frail older US adults. Br J Nutr. 2013;110:172–8.

    PubMed  CAS  Google Scholar 

  179. 179.

    Bollwein J, Volkert D, Diekmann R, Kaiser MJ, Uter W, Vidal K, et al. Nutritional status according to the mini nutritional assessment (MNA1) and frailty in community dwelling older persons: a close relationship. J Nutr Health Aging. 2013;17:351–6.

    PubMed  CAS  Google Scholar 

  180. 180.

    Serra-Prat M, Mans E, Palomera E, Clave P. Gastrointestinal peptides, gastrointestinal motility, and anorexia of aging in frail elderly persons. Neurogastroenterol Motil. 2013;25:291–345.

    PubMed  CAS  Google Scholar 

  181. 181.•

    Allen VJ, Methven L, Gosney MA. Use of nutritional complete supplements in older adults with dementia: systematic review and meta-analysis of clinical outcomes. Clin Nutr. 2013;32:950–7. A meta-analysis showing that oral nutritional supplements may increase weight and improve cognition in persons with dementia.

    PubMed  CAS  Google Scholar 

  182. 182.

    Stange I, Bartram M, Liao Y, Poeschl K, Kolpatzik S, Uter W, et al. Effects of a low-volume, nutrient- and energy-dense oral nutritional supplement on nutritional and functional status: a randomized, controlled trial in nursing home residents. J Am Med Dir Assoc. 2013;14:628.e1–8.

    Google Scholar 

  183. 183.

    Fiatarone MA, O’Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330:1769–75.

    PubMed  CAS  Google Scholar 

  184. 184.

    Kim C-O, Lee K-R. Preventive effect of protein-energy supplementation on the functional decline of frail older adults with low socioeconomic status: a community-based randomized controlled study. J Gerontol A Biol Sci Med Sci. 2013;68:309–16.

    PubMed  CAS  Google Scholar 

  185. 185.••

    Chan DC, Tsou HH, Yang RS, Tsauo JY, Chen CY, Hsiung CA, et al. A pilot randomized controlled trial to improve geriatric frailty. BMC Geriatr. 2012;12:58. One of the first pilot randomized controlled trials examining the effects of both nutritional consultation and exercise in frail older adults, although both interventions on frailty status were only short-term effective (3 months).

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) 2009 Grant 2009E4RM4Z.

Compliance with Ethics Guidelines

Conflict of Interest

Francesco Panza, Vincenzo Solfrizzi, Rosanna Tortelli, Francesco Resta, Carlo Sabbà, and Giancarlo Logroscino declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Francesco Panza.

Additional information

Francesco Panza and Vincenzo Solfrizzi contributed equally to the work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Panza, F., Solfrizzi, V., Tortelli, R. et al. Prevention of Late-life Cognitive Disorders: Diet-Related Factors, Dietary Patterns, and Frailty Models. Curr Nutr Rep 3, 110–129 (2014). https://doi.org/10.1007/s13668-014-0080-8

Download citation

Keywords

  • Diet
  • Alzheimer’s disease
  • Dementia
  • MCI
  • Dietary patterns
  • Frailty
  • Nutrition
  • Cognitive frailty